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Summary.-Groups ofhairless mice were treated with4 skin applications of470 nmol
3-methylcholanthrene (MCA) in benzeneand4of20nmol 12-O-tetradecanoylphorbol-
13-acetate (TPA) in various sequences, twice a week, together and separately. Three
days after the last application, cell kinetic investigations were made comprising
the counting of basal and suprabasal cells, the assessment of hyperplasia, the mitotic
rate by the stathmokinetic method, the labelling index and the specific activity of
DNA after injection of a dose of [3H]dT, and the determination of percentage of cells
in each cell-cycle phase by flow cytometry.
These studies showed that the various treatment schedules with 4 applications
stimulated proliferation and caused epidermal hyperplasia, but there was no
significant difference between the groups in degree of growth stimulation. There
was a significantly higher tumour production by all the coinbinations than by MCA
alone. It was of no significant importance for the tumour production whether the 4
applications of MCA came before or after the 4 of TPA. Alternating treatment
(MCA-TPA, etc.) seemed to give a higher tumour risk than the other treatment
sequences.
The consequences of these results for the two-stage theory of carcinogenesis
(stating that initiation must come first) are discussed, and it is concluded that (at
least under the experimental conditions used here) initiation does not need to come
first for a good tumour yield.
ONE OF THE BASIC ASSUMPTIONS of the
two-stage theory of skin carcinogenesis is
that initiation must take place before
promotion for promotion to operate. E.g.,
as stated by Berenblum & Haran (1955):
"An essential feature of this system is
that the respective mechanisms of the
two stages must be different and inde-
pendent, so that the completed process of
carcinogenesis, which results when pro-
moting action follows initiating action,
should not occur when the procedure is
reversed". It has also been stated directly
that ". . the two stimuli applied sequen-
tially in the reverse order (promoter
followed by initiator) are innocuous"
(Boutwell, 1964). This is still one of the
important corollaries of the two-stage
theory (e.g. Boutwell, 1978; Hecker, 1978;
Weinstein, 1978).
Baba et al. showed in 1967 that the
final skin-cancer incidence was unchanged
whatever the sequence of applications of
:3-methylcholanthrene (MCA) and croton
oil. These results were an interesting
challenge to the two-stage theory, but
have not been taken seriously. We felt it
important to see whether the results of
Baba et al. could be confirmed, and have
therefore studied skin-tumour production
in hairless mice painted first 4 times with
the promoter 1 2-0-tetradecanoyl-phorbol-
13-acetate (TPA) followed by 4 paintings
with the complete carcinogen MCA. We
uised 3 control groups: one with 4 applica-
tions ofMCA before 4 ofTPA (the classical
sequence in two-stage experiments); one
in which the 4 applications of MCA and
TPA were given alternately; and one
receiving 4 applications of MCA only.
We have already published the results
ofpainting hairless mice 5 times with TPAINTERACTION F1 AIC(A & TPA
alone (Iversen & Iversen, 1979). 'rIhe
group with alternating applications of
MCA and TPA was chosen because it
might be of some relevance to the situa-
tion in htuman occupational carcinogenesis,
where the workers are often exposed to
alternating doses of different carcinogenic
influences, e.q. asbestos and cigarette
smoke. Such alternating exposures to 2
or more carcinogens with relatively short
intervals might represent an extra risk.
It is widely held that a high rate of
proliferation (many cells in DNA syn-
thesis) in the target cell population
enhances tumour production induced by a
carcinogen (Pound, 1968). So we also per-
formed a cell-kinetic study of the condi-
tions in the epidermis 3 days after the
4th application (i.e. when the treatment
schedules changed from the one com-
pound to the other).
.MATERIALS ANI) METHODS
Animiials. Hairless mice of the hr/hr Oslo
strain obtained from Gamle Bomholtgaard.
Aarhus, Denmark, were used. Spontaneous
skin tumours have not been seen in these
animals (Laerum. 1973). All the mice were
lhoused in plastic cages in the same room, in
a modern animal department w-ith a constant
light/darkness rhythm, 6-8 in each box, ancl
fed a standard diet and water ad libitunm.
Trhe cages were cleaned and fresh water
supplied 3 times a week.
Application of carcinogenic chem icals.-
T'PA from Consolidated Midland Corp. was
dissolved in reagent-grade benzene so that
0)2 ml contained 20 nmol of TPA. MCA from
Eastman Organic Chemicals was dissolved in
benzene of the same type, to a concentration
of I/160%, so that 0-2 ml contained 470 nmol
MCA. These concentration.s were chosen
because 470 nmol MCA applied 4 times to
hairless mouse skin (Group 1 below) was found
to give - 650o tumour-bearing animals after
13 months' observation. and 20 nmol TPA
is a dose often used for promotion in 2-
stage skin carcinogenesis (e.g. Boutwell. 1978).
The chemicals were applied to the inter-
scapular area of the back skin. The solution,
spread out evenly over the skin.
The mice were divided into 4 experimental
groups: Group 1 (47 animals) received 4
651
applications of MCA. Group 2 (5(0 animals)
r-eceived 4 applications of MCA followed by
4 applications of TPA. Group 3 (48 animals)
received 4 applications of TPA followed by
4 applications of MCA. Group 4 (93 animals)
was given 4 applications of both MCA and
TPA. alternately (i.e. MCA-TPA-MCA-TPA.
etc.). The applications were given twice
weekly; thus there were 3- and 4-day inter-
vals between each application.
Observation ofpapillomas and carcinomas.
The animals w%ere examined once a week
over a period of 13 months. Each tumour
w%as recorded, and registered as a tumour
when present for more than 2 observa-
tions. Whenever possible (i.e. except when
precluded by extensive autolysis) a necropsy
was performed and the tumour examined
histologically. We tried to differentiate
clinically between papillomas and carcinomas
as soon as they developed, by assessing
the degree of infiltration by palpation. All
tumours registered as carcinomas were histo-
logically verified. Infiltration below the
musculus panniculus was used as the criterion
ofmalignancy.
Cell-kinetic studies.-Sixteen extra animals
were used: 4 animals untreated, 4 received 4
applications of MCA, 4 received 4 of TPA,
and 4 were exposed to 4 alternating applica-
tions, MCA-TPA-MCA-TPA. In all cases, the
animals were killed 3 days after the last
applicatioin and cell-kinetic studies made.
The animals were given 0-15 mg Colcemid
(Ciba) in 0-5 ml saline i.p. at 08:00, and
3-5 h later (at 11:30) the animals were given
30,Ci [3H]dT in 05 ml distilled water i.p.
The animals were killed at 12:00, 4 h after
the Colcemid injection. and 0-5 h after the
[3H]dT injection.
The animals were killed by fracture of the
neck, and immediately skinned. Small pieces
of skin were fixed in formalin and processed
for histological examination and autoradio-
graphy. These were dehydrated, embedded
in paraffin, cut at 5 pm, and subjected to
autoradiography by being dipped in Kodak
NTB 2 film emulsion diluted with distilled
water 1: 1. exposed for 2 weeks. developed
and stained with haematoxylin. ln these
sections, the number of basal cells, the
number of non-basal cells, the number of
mitotic figures and the number of labelled
cells were counted in 40 fields with objective
x 100 and eyepiece x 12-5. comprising
918 + 32 ba,sal cells in the untreated mouse.
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From another part of the skin, epidermal
slices were cut with an electrokeratotome
(Skjaeggestad, 1964). Single-cell suspensions
of basal cells were prepared by trypsin treat-
ment, removal of the differentiating cell
layer and shaking (Laerum, 1969; Clausen
et al., 1976). The basal cells were fixed in
ethanol, treated with RNase and stained with
ethidium bromide (Gohde & Dittrich, 1971).
The DNA frequency distributions were
obtained with an ICP 11 pulse cytophoto-
meter (Phywe AG, Gottingen, W. Germany).
Each histogram represented 10,000-20,000
cells. The proportions of cells with G1, S and
G2+M DNA content were calculated by
planimetry (Clausen et al., 1976).
The uptake of [3H]dT per jug epidermal
DNA was studied in other pieces of the
mouse skin. Epidermis was separated from
dermis by a brief heat treatment. Specimens
from 2 animals were pooled, homogenized
in 5 ml of 0-2N perchloric acid at +40C and
centrifuged (10,000 g). The pellet was washed
(2 x 2-5 ml) with ice-cold 0-2N perchloric
acid and once with 4 ml ethanol/ether (1:1,
v/v). DNA in the pellet was hydrolysed in
0-5N perchloric acid at 90°C for 10 min.
After centrifugation, duplicate aliquots of
hydrolysed DNA (0.3 ml) were determined
for radioactivity in a Packard Tri-Carb
liquid-scintillation spectrophotometer. The
DNA content in the supernatant was deter-
mined by the diphenylamine method of
Burton (1968).
Statistical evaluation.-The results are pre-
sented as the tumour rates (the percentage of
tumour-bearing and cancer-bearing animals
in relation to the number of animals alive at
appearance ofthe first papilloma with respect
to time) and thetumouryields (the cumulative
occurrence of all skin tumours and carcin-
omas with respect to time) in the 4 groups.
For the graphs of the yields, the values were
first adjusted to equal size of starting group
(=50 mice).
To evaluate differences in tumour rate, we
have used the methods for "non-incidental"
Treatment -
group 0
1 100
2 100
3 100
4 100
tumours basically described by Peto (1974)
and elaborated with a computer-based test
programme by Peto et al. (1980). This
programme takes care of varying mortality
rates (see Table I) among the experimental
groups. To evaluate the cumulative tumour-
yield curves, we have calculated age-adjusted
cumulative tumour-yield curves, adjusting
for varying mortality, and then used the
method of Gail et al. (1980) based on multiple
times to tumour, Method 3.
RESULTS
Survival
Table I shows the survivalofthe animals
in the 4 groups. Group 1 had the lowest
death rate. There was no difference be-
tween the death rates for Groups 2 and 3,
but Group 4 showed the highest death
rate at the end of the observation period.
However, a log-rank test showed no
significant differences between the death
rates in the various groups.
Cell kinetics
Table II shows the kinetic data for an
untreated, extra control group and for the
experimental Groups 2, 3 and 4. The
values are those actually observed just
before the 5th application in each full
treatment schedule. The hyperplasia was
most pronounced after 4 TPA applica-
tions, but the difference between this
hyperplasia and those provoked by 4
applications of MCA or by MCA-TPA-
MCA-TPA was not significant. MCA
(not TPA) led to the highest labelling
index, DNA-specific activity and fraction
of cells in S. Probably the flux of cells
through S was also highest after 4 MCA
applications. The mitotic rate was
increased after all 3 types of treatment.
TABLE I.-Percentage survival
Months of observation
100
100
100
99
2
100
100
98
99
3
100
100
98
99
4
98
100
98
99
5 6
98 98
98 94
96 85
96 92
7
98
88
85
91
8
94
76
81
86
9
91
71
77
76
10
90
68
73
70
11
83
62
63
51
12
79
52
56
22
13
64
52
56
22
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TABLE II.-Cell kinetic effects 3 days after the last treatment
Variable
Cells/40fields
Basal cells
Supra-basal cells
Average no. of cell layers
Relative hyperplasia (increase in
no. ofsupra-basal cells)
Mitotic rate/40fields/h
Labelled cells in 40fields
Specific activity of DNA
(ct/min/,ug)
Flow-cytometry results
(0% ofcells in each phase)
Gi
S
G2+M
Untreated
controls
918 + 32
611 +48
1 -67
1 00
0 80+0-12
50 + 5
28 0
85+3
11+2
4 +1
MCA x 4 TPA x 4 MCA-TPA-MCA-TPA
929 + 24
856 + 29
1 -92
1 -37
2-60+0-50
88+8
47 -5
83+1
13+2
5 + 1
926 + 18
1000 + 74
2 -08
1 -61
3-30+0-25
72+4
29-5
87+ 1
6 + 1
7+1
933 + 12
894 + 21
1 -96
1 -43
3.30 +0-51
83+6
36 2
82+3
10+2
8+1
<>
Dv
D
100
90
80
70
60
50
40
30
20
10-
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a
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Time in months
FiG. 1. The tumour rate (i.e. tumour-
bearing animals as % of those alive at the
appearance of the first tumour) during the
observation period for each of the 4 experi-
mental groups. Group 1 ( I ) got 4
applications of 470 nmol MCA, Group 2
(.---) got 4 applications of MCA, followed
by 4 applications of 20 nmol TPA. Group 3
(----) got 4 applications of TPA, followed
of 4 of MCA. Group 4 ( ) got 4 applica-
tions of each of the substances alternately,
i.e. MCA-TPA-MCA-TPA, etc. Applica-
tions were given twice weekly.
The differences between the kinetic effects
of the 3 treatment schedules were small;
they all provoked significant hyperplasia
with increased rates of cell proliferation.
The turnover time of epidermal cells was
probably also shortened, because the
hyperplasia was less than would have
been expected if the maturation time had
remained unchanged.
.-.
1 2 34 5 6 7 8 9 10 11;;12 1
1 2 3 4 5 6 7 a 9 10 1 1 12 13
Time in months
FIG. 2.-The carcinoma rate (i.e. carcinoma-
bearing animals as % of those alive at
appearance of the first carcinoma) during
the observation period for each of the 4
experimental groups (Symbols as in Fig. 1).
Tumour rates (papillomas and carcinomas
together)
Fig. 1 shows the tumour rates in the
4 groups. After 10 months all surviving
animals in Groups 2, 3 and 4 were tumour-
bearing. In Group 1, 65% of the animals
had tumours after 13 months. The sig-
nificant difference between Group 1 and
each of the other 3 is obvious. Statistical
evaluations of the tumour rates according
to the method of Peto et al. (1980) for
"non-incidental" tumours are shown in
Table III. There was no significant differ-
ence between Groups 2 and 3. The curve
for Group 4 constantly ran higher than the
others. The difference between Group 4
and the average of 2 and 3 was very
significant.
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TABLE Ill.-Statisticsfor tumour rate
Group comparison
All tumours:
21
39
2
41-
3
4r
2>+ 3\
4f
Carcinomas:
2 }
3J
2l
4
3)
4
2+ 3\
4
One-tailed P P for
Obs/Exp for positive trendlheterogeneitv X2
1 05
0.95
0-83
1-13
0-79
I *15
0-86
1 -21
1 .05
0-95
0-83
1 -12
0-80
1 -13
0-85
1 -20
0-72
0-01
0*005
0-002
0-65
0-10
0-07
0-04
0-57
0-03
0-01
0- 003
0-70
0-20
0 14
0-08
Carcinoma rates
Fig. 2 shows the carcinoma rates in the
4 groups.
The general trends here were the same
as for total tumours. A very significant
difference between treatment with MCA
alone and any ofthe combined treatments
is obvious. The results for the carcinoma
rates were assessed by the statistical
method ofPeto et al. (1980) and are shown
in Table III. There was no significant
difference between Groups 2 and 3, 2
and 4, or 3 and 4.
However, when the result of Group 4
was compared to Groups 2 and 3 together,
the carcinoma rate was just significantly
higher for the alternating-treatment
schedule.
Tumour yields (papillomas and carcinomas
together)
Fig. 3 shows the age-adjusted tumour
yields for the 4 groups. The tumour-yield
curves revealed generally the same pat-
terns as those for tumour rates. The very
significant difference between Group 1 and
the other 3 is obvious. The method of
Peto et al. (1980) is not suitable for total
number of tumours. An assessment of the
differences between the groups with Gail
et al. (1980) Model 3 is shown in Table IV.
There was no significant difference be-
0
E
z
400
350
300
250
200
150
100
50
1 2 3 4 5 6 7 8 9 10 11 12 13
Time in months
FIG. 3. Adjusted tumour yield (i.e. total
no. tumours adjusted for mortality, see
text) during the observation period for
each of the 4 experimental groups
(Symbols as in Fig. 1.)
tween Groups 2 and 3. The tumour yield
for Group 4 ran higher than the others for
the first 8 months, and the difference
between Group 4 and Groups 2 and 3
together was significant during this period.
Later, however, there was no difference
between the groups and the final tumour
yields were equal.
Carcinoma yields
Fig. 4 shows the age-adjusted carcin-
oma yields for the 4 groups. The curves
Significance
NS
High
Very higlh
Very high
NS
NS
NS
Marginal
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TABLE IV.-Statisticsfor tumour b
Group 4 vs
Groups (2+ 3)
All tumours
1
3
4
5
6
7
8
9
10
Summary
29
Carcinomas
1
2
3
4
Summary
5
Final
relative
odds
1 62
1 -58
1 -46
1 -48
1 38
1 -37
1 -27
1 21
1 15
1*10
6-98
10-84
10-32
12-85
9 -97
10-75
6-76
4-76
2 -59
1 -25
1-00 0-00
1-52 4-01
1-39 2-96
1-40 3-17
1-40 3-17
1-40 3- 17
1 2 3 4 5 6 7 8 9 10 1
Time in months
FIG. 4. Adjusted carcinoma yield (i.e.
no. all carcinomas adjusted for vi
mortality, see text) during the obsert
period for each of the 4 experirr
groups (Symbols as in Fig. 1.)
run generally parallel to those for
yields. The highly significant d
between the adjusted curve for I
and each of the other 3 is
An assessment with Gail et al. i
shown in Table IV. There was n
ence between Groups 2 and 3. TI
for Group 4 always ran higher tha
and the difference suggested a
(though not significant) risk for t
nating treatment schedule.
lield DISCUSSION
The 2-stage theory of carcinogenesis
is basically simple and attractive; it can
easily be presented schematically (Bout-
<0001 well, 1978; Hecker, 1978) and it has all
<0o001 the qualities of aparadigm (Kuhn, 1970).
<0o001 Repeated applications of a promoter
<0 001 (e.g. TPA) strongly potentiates the effect <0-01
<o.01 of a single relatively small dose of a
<0 01 complete hydrocarbon carcinogen, and
<0 05 the efficacy of the classical 2-stage
<0o30 protocol in papilloma production is indis-
putable. The 2-stage theory, however, is
I an interpretation with many corollaries.
<005 Its basic assumption is that the synergism
<0110 is due to an essential, qualitative differ-
0 07 ence between initiation and promotion
0 07 (Laerum & Iversen, 1981). One of the
0 07 most important corollaries of the 2-
stage theory is that initiation must
come first, for maximum tumour yield.
Our results show, however, that at the
4 dose levels used in this study, the inverted
treatment schedule was almost as effective
.2 as the classical one. Thus, the results of
Baba et al. (1967) were basically con-
1/ ."-3 firmed. It may be objected that both our
doses of MCA and those of Baba et al.
were too high, and represented a com-
pletely carcinogenic, not an initiating,
dose. This is accepted, but still the results
deserve attention.
11 12 13 It was shown already by Mottram (1944)
that promoter treatment before initiation
gave a high tumour incidence, and similar
total results were demonstrated by Roe (1959).
axying Pound (1963) showed that painting mouse vation
tental skin with croton oil before an injection of
urethane led to an augmented tumour
yield in the pretreated area. Tannenbaum
tumour et al. (1964) showed that pretreatment of
Lifference mouse skin with croton oil caused a small
Group 1 but significant increase in the incidence of
obvious. skin tumours and carcinomas, when the
model is mice were thereafter treated with a com-
o differ- plete carcinogen. Shinozuka & Ritchie
he curve (1967) reported that the yield of papil-
in these, lomas induced by a single application of
t higher 7,12-dimethylbenz(a)anthracene (DMBA)
,he alter- followed by repeated applications of
croton oil, could be increased by an
801
al
-S
0
z
io1
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application of croton oil 23 h before the
carcinogen, and the same was true when
a single injection of urethane was used as
initiator.
Pound (1968) showed that treatment
with acetic acid or croton oil 24 h before
a single application of a complete hydro-
carbon carcinogenproducedmoretumours.
Goerttler & Loehrke (1976) showed that
treatment of mouse skin with TPA,
followed by a small dose of DMBA, and
followed again by continued treatment by
TPA alone, increased the tumour yield
considerably over treatment with a car-
cinogen plus TPA, but without pretreat-
ment. The orthodox explanation of these
results is that the rate of DNA synthesis,
or the rate of cellular proliferation, at the
time of an application of an electrophilic
hydrocarbon carcinogen is ofgreat import-
ance for the final tumour production.
Pretreatment with a promoter increases
the rate of epidermal proliferation, which
increases the binding of the ultimate
carcinogen to DNA, and thus one main-
tains that the two-stage theory, which
says that initiation must comefirst, is not
invalidated by such results.
Our cell-kinetic results, however, show
that at the dose levels used here there is
no significant difference between the pro-
liferative stimulation of the epidermis by
primary treatment with either MCA or
TPA. The rate of cell proliferation is
greatly increased by both TPA and MCA
treatment, and the two substances pro-
voke comparable hyperplasias. Cell-kinetic
alterations produced by TPA cannot
therefore explain why the inverted experi-
ment was as effective as the traditional
one. It can thus be concluded that the
reverse experiment is not innocuous (not
even less innocuous), and, under these
experimental conditions, initiation need
not come first.
The reason why the reverse experiment
usually ends with few or no tumours may
be that in a classical 2-stage experiment
the initiating dose of complete carcinogen
is applied to a very thin, "virgin", mouse
epidermis. What matters for carcino-
genesis is probably the effective dose of
the ultimate carcinogen reaching some
critical macromolecules (often DNA?) in
the basal cells. When, in the reverse
situation, a small initiating dose of a
carcinogen is given topically after weeks
of TPA treatment, it is applied to an
epidermis that is hyperplastic and has a
high rate of cell turnover. The dose reach-
ing the basal cells is probably only a
fraction of what would reach these cells
in an undisturbed epidermis. The rapid
proliferation also reduces the persistence
ofthe carcinogen in the epidermis, and the
probability of a transformed cell being
shed by the rapid proliferation is probably
much greater than in the unstimulated
condition. Finally, the observation period
after the final delivery of the initiator
has always been short.
We therefore feel that our results,
together with the reports mentioned, cast
some doubt on one ofthe basic corollaries
ofthe 2-stage theory.
The difference between the tumour
production provoked by MCA alone and
by the combined treatment shows that
TPA and MCA act synergistically and are
not only additive. Five paintings with
17 nmol TPA give very few tumours
within 13 months (but several later) as
shown previously (Iversen & Iversen,
1979).
Thus the synergism between MCA and
TPA is considerable and, under the condi-
tions used here, it is manifested whatever
the sequence of application.
Our study also indicates a trend for
further augmented tumour production
following systematic alternating treat-
ments with a strongandaweakcarcinogen.
This is probably the commonest situation
in human carcinogenesis, whererisk factors
in the industrial environment continu-
ously alternate with risk factors related
to personal life style. Already Berenblum
(1941) showed that alternate applications
of promoter and initiator gave many
tumours on mouse skin. Salaman & Roe
(1953) got the highest tumour yield from
alternate treatments of urethane and
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croton oil over a period of 21 weeks.
Schoental (1963) demonstrated a synergis-
tic effect of hydrocarbon and nitro-
sourethane carcinogens given alternately.
Boutwell (1976) reported the results of
weekly paintings with different doses of
DMBA alternating with a constant weekly
dose of croton oil (0.5% solution) and
compared these results with those after
repeated weekly treatments with car-
cinogen alone. The results were that, for
each dose level of the strong carcinogen,
there was a higher tumour yield when
croton oil was also given in sequential
paintings. The increase in tumorigenicity
after sequential delivery of carcinogens
may also be relevant to occupational
carcinogenesis. Many workers are also
cigarette smokers, and they are therefore
exposed to an industrial carcinogen in
their working time and to cigarette smoke
in their leisure time (see e.g. Kreyberg,
1978). Meurman et al. (1974) estimated
the risk factor of combined, alternating
exposure in the following way (using a
multiplicative model and certain specific
assumptions):
non-smokers and non-asbestos 1 .0
workers
asbestos workers (non-smokers) 1 *4
smokers (non-asbestos workers) 12*0
smokers and asbestos workers 17 *0
combined
Selikoff et al. (1968) estimated the com-
bined risk factor to be as high as 92. Our
results indicate that the highest risk of
tumour development in skincarcinogenesis
also occurs after alternate exposures to
strong and weak carcinogens.
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